Back
Compass Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
55
CMPX
Compass Therapeutics
Last Price:
$2.54
Seasonality Move:
0.44%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMPX is experiencing slight buying pressure.
Compass Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Buy |
| 20-day SMA: | 2.28 | Buy |
| 50-day SMA: | 2.04 | Buy |
| 200-day SMA: | 2.05 | Buy |
| 8-day EMA: | 2.36 | Buy |
| 20-day EMA: | 2.28 | Buy |
| 50-day EMA: | 2.18 | Buy |
| 200-day EMA: | 2.06 | Buy |
Compass Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 58.91 | Buy |
| Chaikin Money Flow: | 588014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.41) | Buy |
| Bollinger Bands (100): | (1.8 - 2.94) | Buy |
Compass Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics Stock
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 2.40 while CMPX 8-day simple moving average is 2.39, which is a Buy signal.
-
The stock price of CMPX is 2.40 while Compass Therapeutics 20-day SMA is 2.28, which makes it a Buy.
-
Compass Therapeutics 50-day simple moving average is 2.04 while CMPX share price is 2.40, making it a Buy technically.
-
CMPX stock price is 2.40 and Compass Therapeutics 200-day simple moving average is 2.05, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
55
Compass Therapeutics (CMPX)
is a Buy
Is Compass Therapeutics a Buy or a Sell?
-
Compass Therapeutics stock is rated a BuyThe current Compass Therapeutics [CMPX] share price is $2.40. The Score for CMPX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics Stock Info
Market Cap:
331.9M
Price in USD:
2.40
Share Volume:
1.3M
Compass Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
0.77
Buy
55
Compass Therapeutics (CMPX)
is a Buy
Compass Therapeutics Share Price Forecast
-
What is the Compass Therapeutics stock price today?The Compass Therapeutics stock price is 2.40 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics is not overvalued.
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 2.40 while CMPX 8-day exponential moving average is 2.36, which is a Buy signal.
-
The stock price of CMPX is 2.40 while Compass Therapeutics 20-day EMA is 2.28, which makes it a Buy.
-
Compass Therapeutics 50-day exponential moving average is 2.18 while CMPX share price is 2.40, making it a Buy technically.
-
CMPX stock price is 2.40 and Compass Therapeutics 200-day simple moving average is 2.06, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics
Is Compass Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Compass Therapeutics
Should I short Compass Therapeutics stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Compass Therapeutics is a Buy
-
Compass Therapeutics Relative Strength Index (RSI) is 58.91, which suggest Compass Therapeutics is overbought
-
The Bollinger Bands (25) for Compass Therapeutics is (2.07 - 2.41), which suggest Compass Therapeutics is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics is (1.8 - 2.94), which suggest Compass Therapeutics is a Buy
* Compass Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.